Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma
Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page
- Check3 days agoChange DetectedThe revision label on the page changes from v3.6.3 to v3.6.4, signaling an updated version of the record history display. This is a system-level update to the page version, not a modification to the trial data or study details.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe record history now shows a newer revision label, v3.6.3, replacing the prior v3.6.2, indicating an updated revision of the page content.SummaryDifference0.0%

- Check32 days agoChange DetectedThe record history now includes a new revision labeled v3.6.2, replacing the prior v3.6.0, indicating an update to the page's revision history.SummaryDifference0.0%

- Check46 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and a new record revision (v3.6.0) was added, replacing the prior revision (v3.5.5).SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now shows the latest revision tag, v3.5.5, replacing the previous v3.5.4, indicating an incremental update to the page’s interface.SummaryDifference0.0%

- Check74 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the revision history, and the previous 'Revision: v3.5.3' entry was removed. This updates the history to reflect the latest site revision.SummaryDifference0.0%

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma
Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.